Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

24

Jun 2019

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-APOC3

Arrowhead Pharmaceuticals Inc announced that the US Food and Drug Administration FDA has granted orphan drug designation to AROAPOC for the treatment of familial chylomicronemia syndrome FCS There is no currently available therapy in the US that can adequately treat FCS

21

Jun 2019

WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing

WuXi Biologics a leading global openaccess biologics technology platform company offering endtoend solutions for biologics discovery development and manufacturing announced that it planned to expand the new stateoftheart integrated biologics conjugation solution center to include commercial manufact...

20

Jun 2019

Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement

Ultragenyx Pharmaceutical Inc a biopharmaceutical company focused on the development of novel products for serious rare and ultrarare genetic diseases and Arcturus Therapeutics Holdings Inc a leading messenger RNA medicines company today announced that they have expanded their collaboration to disco...

20

Jun 2019

Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases

Gilead Sciences Inc and Nurix Therapeutics Inc a company discovering drugs that harness the bodys natural process to control protein levels today announced a global strategic collaboration to discover develop and commercialize a pipeline of innovative targeted protein degradation drugs for patients...

19

Jun 2019

Premier Inc. Partners with Pensiamo Inc. and UPMC to Launch AI-Powered Pharmaceutical Supply Chain Solution

Premier Inc a healthcare improvement company and Pensiamo Inc a cognitive supply chain company have partnered to launch a new pharmaceutical supply chain solution that was codeveloped with UPMC a worldrenowned healthcare provider and insurer

press releasesRead more...

24

Jun 2019

Clinigen Broadens Partnership with Accord Healthcare to Supply and Distribute Cardioxane® and Savene® in Poland

Clinigen Group plc the global pharmaceutical and services company announces that its Commercial Medicines business has signed an exclusive agreement with Accord Healthcare Accord to supply and distribute Clinigens speciality medicines Cardioxane and Savene in Poland

24

Jun 2019

Parexel Launches Enhanced Integrated Functional Service Provider Model to Drive Delivery of Innovative Clinical Research Partnerships

Parexel a leading provider of solutions to accelerate the development and delivery of innovative new therapies to market to improve world health from Clinical through to Commercialization today launched an enhanced integrated outsourcing delivery model for Functional Service Provider FSP services at...

21

Jun 2019

Orion Biotechnology Reports Additional Positive Preclinical Data for OB-002 in the Treatment of Colorectal Cancer

Orion Biotechnology Canada Ltd today announced new preclinical data evaluating the efficacy of OB PRANTES in colorectal cancer BALBc mice were inoculated subcutaneously with the CT colorectal cancer cell line Seven days after inoculation the mice were randomized to receive intraperitoneal treatment...

20

Jun 2019

Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel

Gamida Cell Ltd a leading cellular and immune therapeutics company and Lonza SWX LONN today announced that the companies have entered into a strategic manufacturing agreement The agreement provides for the future commercial production after potential FDA approval of omidubicel Gamida Cells investiga...

20

Jun 2019

Melinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia

Melinta Therapeutics Inc a commercialstage company focused on the development and commercialization of novel antibiotics to treat serious bacterial infections today announced the US Food and Drug Administration FDA has accepted a supplemental New Drug Application sNDA for BAXDELA delafloxacin for pr...

EventsRead more...

24 - 26

Jun 2019

Digital Pharma West 2019

Hyatt Regency San Francisco Airport

24 - 25

Jun 2019

10th Summit on Biosimilars

New York Marriott East Side Hotel

25 - 27

Jun 2019

2nd CPLM Summit

Hanson Wade
Hyatt Regency Boston

26 - 28

Jun 2019

4th Microbiome Movement - Drug Development Summit

Microbiome Movement
Revere Hotel Boston Common

Advertisements

Rousselot - X-PURE®

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...

EDITORIAL SECTION